A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom.

MLA

Campling, James, et al. “A Review of Evidence for Pneumococcal Vaccination in Adults at Increased Risk of Pneumococcal Disease: Risk Group Definitions and Optimization of Vaccination Coverage in the United Kingdom.” Expert Review of Vaccines, vol. 22, no. 1, Jan. 2023, pp. 785–800. EBSCOhost, https://doi.org/10.1080/14760584.2023.2256394.

APA

Campling, J., Vyse, A., Liu, H.-H., Wright, H., Slack, M., Reinert, R.-R., Drayson, M., Richter, A., Singh, D., Barlow, G., Kassianos, G., & Ellsbury, G. (2023). A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom. Expert Review of Vaccines, 22(1), 785–800. https://doi.org/10.1080/14760584.2023.2256394

Chicago

Campling, James, Andrew Vyse, Hui-Hsuan Liu, Hannah Wright, Mary Slack, Ralf-Rene Reinert, Mark Drayson, et al. 2023. “A Review of Evidence for Pneumococcal Vaccination in Adults at Increased Risk of Pneumococcal Disease: Risk Group Definitions and Optimization of Vaccination Coverage in the United Kingdom.” Expert Review of Vaccines 22 (1): 785–800. doi:10.1080/14760584.2023.2256394.